Investor Says Biotech Co. Hid Issues Leading To Delays
A CorMedix Inc. investor launched a derivative shareholder lawsuit Wednesday, claiming that the biopharmaceutical firm's share value plummeted when the public learned that previously undisclosed manufacturing issues were delaying regulatory approval...To view the full article, register now.
Already a subscriber? Click here to view full article